Hardly any other industry places such high demands on warehousing and material flow processes as the pharmaceutical industry. Medicines, active ingredients, and medical products must not only be in the right place at the right time; their quality and safety must be guaranteed and traceably documented throughout the entire process.
This also applies to intralogistics. In the pharmaceutical industry, warehouses have long since ceased to be mere storage facilities. They are part of a quality-critical overall system in which temperature conditions, batches, expiration dates, status information, and movements must be reliably monitored. An incorrectly stored item, an untraceable inventory movement, or an error in order picking can have far-reaching consequences beyond a mere delivery delay.
Logistics, IT, and quality assurance are therefore closely intertwined. Automated warehouse and material flow systems must not only operate efficiently but also support regulatory requirements, capture data without gaps, and execute defined processes in a reproducible manner.
Pharmaceutical logistics begins with quality assurance
A key term in the pharmaceutical sector is GxP. The acronym stands for “Good x Practice” and encompasses various sets of regulations and quality requirements, such as Good Manufacturing Practice (GMP) or Good Distribution Practice (GDP). Which specific requirements apply depends, among other things, on the respective process and product.
For intralogistics, this means that warehouse and material flow processes cannot be considered in isolation from quality requirements. The question is not merely whether a system can execute an order quickly and reliably. It is equally important to be able to demonstrate what happened to which product, when, and under what conditions this process took place.
This also changes the importance of warehouse management. Inventory is not managed solely by item number and quantity. Depending on the application, additional information plays a decisive role:
- Batch or lot number
- Manufacture and expiration dates
- Storage status, such as “quarantine,” “released,” or “blocked”
- Storage conditions and temperature ranges
- Serial numbers
- Origin and destination of the goods
- Time and type of inventory movement
- Processes involved and, if applicable, users
This information must be processed consistently. A warehouse management system thus becomes an important component of quality assurance.
Traceability: Every movement must be traceable
In pharmaceutical logistics, traceability is more than just a convenient additional feature. It is an essential prerequisite for being able to react quickly in the event of deviations, complaints, or recalls.
It is not enough to know, for example, that 500 packages of a specific medication are in the warehouse. It may be relevant to know which batch is located at which storage location, when it was put into storage, what quantities have already been removed from storage, and where they went.
Reliable traceability must therefore work in both directions. Starting with a batch, it should be possible to trace the storage and transport processes it has undergone. Conversely, in the event of a recall, for example, it must be possible to determine which inventory and, if applicable, which shipments are affected by a specific batch.
Automated warehouses generate large amounts of process data. What matters is not just storing this data, but linking it consistently. Material flow control, warehouse management, ERP systems, scanners, sensors, and, where applicable, other systems must provide a unified and traceable view of the process.
FEFO Instead of Simply FIFO
A classic warehouse principle is FIFO—“First In, First Out.” In the pharmaceutical industry, this principle is often insufficient. This is where FEFO—First Expired, First Out—plays a much more important role.
Under the FEFO principle, decisions are not primarily based on which goods were stored first. Rather, the decisive factor is which unit or batch reaches its expiration date first.
This may sound simple at first, but it poses several challenges for intralogistics. A warehouse management system must know expiration dates and take them into account when selecting inventory. At the same time, regulatory or operational requirements may override the automatic selection. For example, a batch may have the earliest expiration date but still be in quarantine or not yet approved for picking for some other reason.
The inventory strategy is thus determined by several criteria:
Item + Batch + Status + Expiration Date + Storage Conditions + Process Specifications
Reliable system support is crucial, especially when dealing with large inventories. Manual decisions not only increase the workload but also the risk of errors.
Quarantine is a process—not just a storage location
A distinctive feature of pharmaceutical warehousing processes is the variety of inventory statuses. Goods are not automatically released for any further use upon delivery or manufacture.
Typical statuses may include, for example:
- Quarantine
- Released
- Blocked
- Set aside
- Scheduled for destruction
These statuses must be clearly mapped in the system. Physically available inventory must not automatically be process-available as well.
This is an important difference from traditional warehouse logistics. The information “inventory available” is not sufficient. A system must also be able to answer: Can this inventory be used for this process?
In automated warehouses, this logic can be closely integrated with material flow control. For example, an order for released goods must not be allowed to access a pallet that, while physically present in the warehouse, still has the “quarantine” status.
However, the physical separation of inventory is often only part of the solution. Equally important is the logical separation within the IT systems. After all, even a correctly labeled quarantine area offers little security if the underlying software allows unauthorized access.
Temperature Control: When Storage Conditions Are Part of Product Quality
Many pharmaceutical products are sensitive to temperature fluctuations. Controlled storage within defined temperature ranges is therefore crucial.
Depending on the product, different requirements may apply—such as room temperature, refrigerated areas, or frozen storage. It is not just a matter of maintaining the target temperature; monitoring, documentation, and handling deviations are equally important.
Intralogistics must therefore be able to handle a wide range of conditions. Sensors record temperature readings, systems monitor threshold values, and processes must define what happens in the event of a deviation.
For example: If a critical temperature is exceeded in a refrigerated area, the response must not consist solely of a warning message. Depending on the process, affected inventory may need to be locked, movements prevented, and quality assurance notified.
This makes it clear that sensor technology and warehouse management should not be considered independently of one another. Only the interplay of measurement, evaluation, status management, and process control makes temperature monitoring a robust quality process.
Warehouse technology itself must also be taken into account. Cold storage areas, airlocks, doors, conveyor systems, and automated storage and retrieval machines can all influence environmental conditions. The design of a pharmaceutical warehouse is therefore always a matter of the interplay between the building, technology, software, and organizational processes.
Serialization and Batch Management Increase the Level of Detail
Serialization makes traceability even more granular. While traditional batch management considers specific quantities as a group, with serialized products, each individual sales unit can be identified by a unique serial number.
This places additional demands on intralogistics. Data must be captured at the right points, correctly assigned, and processed across the relevant systems.
This gives rise to a typical challenge in modern pharmaceutical logistics: the volume of information is growing faster than the number of physical goods movements. Although a pallet moves physically as a single unit, it may contain products with different lots, serial numbers, or status information.
The systems must be able to distinguish between these levels without unnecessarily complicating the material flow.
This becomes particularly important at interfaces. Information from merchandise management, warehouse management, production systems, track-and-trace solutions, or other specialized applications must align. Otherwise, errors at an interface can have a direct impact on traceability.
Validation and Qualification: Functionality Alone Is Not Enough
Another difference from many other industries lies in the importance of validation and qualification.
With a typical logistics system, the primary question is often: Does the solution work as intended?
In the pharmaceutical sector, a second question arises: Is it documented and verified that it functions reproducibly and in accordance with the defined requirements?
This is not just about the software itself. Depending on the system and process, factors such as warehouse technology, sensor systems, interfaces, and automated workflows may be relevant.
The requirements must first be defined. Subsequently, it is verified and documented whether the solution meets these requirements. Changes to the system must also be managed carefully. This applies, for example, to new software versions, adjustments to interfaces, changes to warehousing strategies, or expansions of automation.
For IT and intralogistics, this places higher demands on change management. A spontaneous “Let’s just quickly change that in the system” approach is ill-suited to an environment where processes must be traceable, reproducible, and documented.
Availability Is More Than Just a Matter of Productivity
Pharmaceutical supply chains are often time-sensitive. Hospitals, pharmacies, wholesalers, and other customers expect a reliable supply. At the same time, warehouse processes cannot be simplified at will due to regulatory requirements.
High availability thus becomes a balancing act: The system must be robust and high-performing without circumventing control mechanisms.
Automated warehouse and material flow systems, in particular, must therefore be designed to handle disruptions. What happens if the conveyor system fails? How is an inaccessible warehouse area handled? What happens in the event of a communication error between warehouse management and material flow control? And how can we ensure that no inventory or status information is lost after a disruption?
Emergency plans and defined recovery processes are therefore a crucial component of process reliability. A system must not only function during normal operation; it must also be able to handle deviations in a controlled manner.
Data Integrity as the Foundation of Process Reliability
The more pharmaceutical warehouses are automated and digitized, the greater the importance of data integrity becomes.
A product that is physically stored correctly can still become a problem due to an incorrect data record. For example, if a batch has the wrong status in the system or an expiration date is processed incorrectly, a material flow that is otherwise functioning properly may execute an incorrect process.
Therefore, data must not only be available but also accurate, complete, consistent, and traceable.
This applies, among other things, to:
- Master data
- Batch and serial numbers
- Inventory information
- Status information
- Movement data
- User and authorization information
- Process and change logs
For warehouse IT design, this means that data structures and process logic should be considered together from the very beginning. Adding regulatory requirements later is often significantly more time-consuming than incorporating them into the design during the system selection and project planning phases.
Automation creates opportunities—and new requirements
Automated high-bay warehouses, shuttle systems, conveyor technology, autonomous transport systems, and robot-assisted solutions can offer significant advantages in the pharmaceutical industry. They reduce manual intervention, enable high process speeds, and create reproducible workflows.
At the same time, automation shifts the nature of errors.
Whereas in the past an employee might have selected the wrong storage location, today, for example, a faulty system rule can systematically misallocate inventory. A manual process may cause a single error; faulty automation logic, on the other hand, can affect a large number of operations.
Therefore, automation does not automatically equate to greater process reliability. The quality of the underlying processes and their technical implementation is crucial.
A good pharmaceutical logistics concept therefore takes into account not only normal operations but also special cases: blocked batches, damaged goods, deviating temperature readings, missing data, technical malfunctions, or manual interventions.
People Remain Part of the System
Despite increasing automation, people remain a vital component of pharmaceutical logistics. Employees perform checks, handle exceptions, make decisions regarding deviations, and intervene when process disruptions occur.
It is precisely these manual interventions that must be seamlessly integrated into the process logic. A system should be able to document in a traceable manner when an intervention took place and what effects it had.
This is not an argument against manual processes. It is an argument for their clear definition.
The crucial question, therefore, is not whether a process is executed manually or automatically. What matters is whether it is controlled, traceable, and reproducible.
What Sets High-Performance Pharmaceutical Logistics Apart
High-performance intralogistics in the pharmaceutical industry must meet several requirements simultaneously. It must be efficient enough for high throughput, flexible enough for different products, and robust enough for operations with high availability requirements.
At the same time, regulatory requirements must be taken into account without unnecessarily complicating the operational process.
In practice, this means a close integration of:
- Warehouse strategy and process definition: Rules for putaway, picking, FEFO, quarantine, and inventory status must be clearly defined.
- Warehouse Management and Material Flow Control: The software must not only manage inventory but also derive reliable and traceable material movements from it.
- Automation and Quality Assurance: Automated processes must reliably adhere to the defined quality and status rules.
- Data and Traceability: Relevant information must be consistently recorded and made available in a traceable manner throughout the entire process.
- Validation and Change Management: Systems and processes must be introduced in a controlled manner, tested, and handled appropriately when changes occur.
- Fault and Exception Handling: Deviations, too, must trigger defined and traceable processes.
These points also illustrate why pharmaceutical intralogistics can rarely be solved with a single, isolated technology. The interaction of the various components is crucial.
Conclusion: In pharmaceutical logistics, the process is part of quality
Intralogistics in the pharmaceutical industry is more than just the efficient movement of goods. Warehouse processes are directly linked to quality, safety, and traceability.
Batches, expiration dates, FEFO, serialization, quarantine, and temperature control are therefore not simply additional functions that can be added to an existing logistics system. They shape the logic of the entire system.
At the same time, automation increases the demands on data integrity, interfaces, validation, and controlled changes. A high-performance warehouse must not only operate quickly and reliably; it must also be able to provide traceability at all times – which inventory is located where, what its status is, which processes it has undergone, and why a particular decision was made.
This is precisely where the unique challenge of pharmaceutical intralogistics lies: efficiency and compliance do not exist separately from one another. They must be integrated into a single, end-to-end process.
Anyone planning or modernizing pharmaceutical warehouse processes should therefore not start by asking which automation technology to use. Rather, the first step is to define the processes, requirements, and data that the warehouse must reliably manage. Only then can one determine which combination of warehouse technology, software, material flow control, and quality assurance actually makes sense.
After all, in the end, it is not the performance of a single system alone that determines the quality of pharmaceutical logistics. What matters is whether the overall system comprising people, processes, software, and technology works together reliably – both during normal operations and when the next deviation occurs.
More interesting articles on this topic:
